company background image
SUPRIYA logo

Supriya Lifescience NSEI:SUPRIYA Stock Report

Last Price

₹410.50

Market Cap

₹33.0b

7D

2.0%

1Y

69.7%

Updated

17 Jul, 2024

Data

Company Financials +

Supriya Lifescience Limited

NSEI:SUPRIYA Stock Report

Market Cap: ₹33.0b

SUPRIYA Stock Overview

Engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide.

SUPRIYA fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance4/6
Financial Health6/6
Dividends1/6

Supriya Lifescience Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Supriya Lifescience
Historical stock prices
Current Share Price₹410.50
52 Week High₹424.70
52 Week Low₹233.30
Beta0.29
11 Month Change3.05%
3 Month Change11.94%
1 Year Change69.70%
33 Year Changen/a
5 Year Changen/a
Change since IPO5.03%

Recent News & Updates

We Think You Should Be Aware Of Some Concerning Factors In Supriya Lifescience's (NSE:SUPRIYA) Earnings

Jun 05
We Think You Should Be Aware Of Some Concerning Factors In Supriya Lifescience's (NSE:SUPRIYA) Earnings

Little Excitement Around Supriya Lifescience Limited's (NSE:SUPRIYA) Earnings

May 10
Little Excitement Around Supriya Lifescience Limited's (NSE:SUPRIYA) Earnings

Recent updates

We Think You Should Be Aware Of Some Concerning Factors In Supriya Lifescience's (NSE:SUPRIYA) Earnings

Jun 05
We Think You Should Be Aware Of Some Concerning Factors In Supriya Lifescience's (NSE:SUPRIYA) Earnings

Little Excitement Around Supriya Lifescience Limited's (NSE:SUPRIYA) Earnings

May 10
Little Excitement Around Supriya Lifescience Limited's (NSE:SUPRIYA) Earnings

Lacklustre Performance Is Driving Supriya Lifescience Limited's (NSE:SUPRIYA) Low P/E

Feb 09
Lacklustre Performance Is Driving Supriya Lifescience Limited's (NSE:SUPRIYA) Low P/E

Supriya Lifescience's (NSE:SUPRIYA) Shareholders May Want To Dig Deeper Than Statutory Profit

May 28
Supriya Lifescience's (NSE:SUPRIYA) Shareholders May Want To Dig Deeper Than Statutory Profit

Market Cool On Supriya Lifescience Limited's (NSE:SUPRIYA) Earnings Pushing Shares 27% Lower

May 07
Market Cool On Supriya Lifescience Limited's (NSE:SUPRIYA) Earnings Pushing Shares 27% Lower

Shareholder Returns

SUPRIYAIN PharmaceuticalsIN Market
7D2.0%0.8%0.8%
1Y69.7%51.4%45.4%

Return vs Industry: SUPRIYA exceeded the Indian Pharmaceuticals industry which returned 51.4% over the past year.

Return vs Market: SUPRIYA exceeded the Indian Market which returned 45.4% over the past year.

Price Volatility

Is SUPRIYA's price volatile compared to industry and market?
SUPRIYA volatility
SUPRIYA Average Weekly Movement5.5%
Pharmaceuticals Industry Average Movement5.7%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.7%
10% least volatile stocks in IN Market4.2%

Stable Share Price: SUPRIYA has not had significant price volatility in the past 3 months.

Volatility Over Time: SUPRIYA's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1987392n/awww.supriyalifescience.com

Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. It offers anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, and anti-malarial products, as well as vitamins and xanthine derivatives. The company was founded in 1987 and is headquartered in Mumbai, India.

Supriya Lifescience Limited Fundamentals Summary

How do Supriya Lifescience's earnings and revenue compare to its market cap?
SUPRIYA fundamental statistics
Market cap₹33.04b
Earnings (TTM)₹1.19b
Revenue (TTM)₹5.70b

27.7x

P/E Ratio

5.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SUPRIYA income statement (TTM)
Revenue₹5.70b
Cost of Revenue₹2.22b
Gross Profit₹3.49b
Other Expenses₹2.30b
Earnings₹1.19b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)14.80
Gross Margin61.12%
Net Profit Margin20.88%
Debt/Equity Ratio0%

How did SUPRIYA perform over the long term?

See historical performance and comparison

Dividends

0.2%

Current Dividend Yield

5%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.